Black pearl in the LIFE study: angiotensin-II receptor blockade on atrial fibrillation for future personalized medicine.
Ogimoto
Akiyoshi
A
Shigematsu
Yuji
Y
Hara
Yuji
Y
Ohtsuka
Tomoaki
T
Miki
Tetsuro
T
Higaki
Jitsuo
J
D001741:Black or African American; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects* / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001262:Atenolol / Q000009:adverse effects* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D019808:Losartan / Q000009:adverse effects* / Q000627:therapeutic use; D012008:Recurrence; D044465:White People
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D001262:Atenolol; D019808:Losartan